Raymond James & Associates Silk Road Medical Inc Transaction History

Raymond James & Associates

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$14.99 - $32.65 $18,422 - $40,126	-1,229 Reduced 3.94%	29,955 $449,000
Q2 2023 Jul 25, 2023	BUY	$29.76 - $46.14 $31,009 - $48,077	1,042 Added 3.46%	31,184 $1.01 Million
Q1 2023 Apr 14, 2023	SELL	$38.09 - $57.79 $87,416 - $132,628	-2,295 Reduced 7.08%	30,142 $1.18 Million
Q4 2022 Feb 08, 2023	BUY	$40.54 - $56.2 $581,019 - $805,458	14,332 Added 79.16%	32,437 $1.71 Million
Q3 2022 Oct 25, 2022	BUY	$36.98 - $49.2 $46,372 - $61,696	1,254 Added 7.44%	18,105 $815,000
Q2 2022 Aug 12, 2022	SELL	$28.03 - $45.8 $23,012 - $37,601	-821 Reduced 4.65%	16,851 $613,000
Q1 2022 May 11, 2022	BUY	$29.24 - $44.06 $96,608 - $145,574	3,304 Added 23.0%	17,672 $730,000
Q4 2021 Feb 08, 2022	SELL	$39.32 - $61.61 $40,892 - $64,074	-1,040 Reduced 6.75%	14,368 $612,000
Q3 2021 Nov 02, 2021	BUY	$44.0 - $65.8 $12,892 - $19,279	293 Added 1.94%	15,408 $848,000
Q2 2021 Aug 11, 2021	SELL	$44.66 - $63.06 $26,394 - $37,268	-591 Reduced 3.76%	15,115 $723,000
Q1 2021 May 14, 2021	BUY	$46.31 - $62.7 $727,344 - $984,766	15,706 New	15,706 $796,000

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.